Summary
Danaher Corporation (DHR) filed an 8-K on January 10, 2017, to furnish presentation slides for their J.P. Morgan Healthcare Conference. The filing primarily provides updated financial performance information for the estimated full year 2016, focusing on non-GAAP measures. Key financial insights include an estimated Free Cash Flow from Continuing Operations of $2.5 billion, derived from estimated Operating Cash Flows of $3.1 billion less capital expenditures of $0.6 billion. The company highlighted a strong Free Cash Flow to Net Earnings conversion ratio of approximately 120%, with estimated Net Earnings from Continuing Operations at $2.1 billion. Management emphasizes that free cash flow is a valuable metric for investors to assess Danaher's ability to generate cash for balance sheet strengthening, business investment, and strategic growth opportunities, although it should be considered alongside GAAP operating cash flow.
Key Highlights
- 1Danaher Corporation furnished presentation slides on January 10, 2017, for the J.P. Morgan Healthcare Conference.
- 2The presentation included anticipated financial performance for the estimated full year 2016.
- 3Estimated Free Cash Flow from Continuing Operations (Non-GAAP) for the year ended December 31, 2016, was $2.5 billion.
- 4This free cash flow was generated from estimated Operating Cash Flows (GAAP) of $3.1 billion, less capital expenditures of $0.6 billion.
- 5Estimated Net Earnings from Continuing Operations (GAAP) for the year ended December 31, 2016, were $2.1 billion.
- 6Danaher reported a strong Non-GAAP Free Cash Flow to Net Earnings Conversion Ratio of approximately 120%.
- 7The company believes free cash flow provides investors with additional insight into cash generation capabilities for reinvestment and strategic growth.